Literature DB >> 8550477

Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis.

G J Veenstra1, F F Cremers, H van Dijk, A Fleer.   

Abstract

Coagulase-negative staphylococci have emerged as important pathogens in infections associated with intravascular devices. Microbial adherence to biomaterial surfaces is a crucial step in the pathogenesis of these infections. Staphylococcal surface proteins (herein referred to as SSP-1 and SSP-2) are involved in the attachment of Staphylococcus epidermidis 354 to polystyrene. In the present study we show that the adhesin protrudes from the cell surface as a fimbria-like polymer. Furthermore, in vitro proteolytic cleavage of SSP-1 produces an SSP-2-like protein which coincides with a loss of adhesive function. SSP-1 expression is down-regulated in a phenotypical variant of S. epidermidis 354 whereas SSP-2 expression is not. These results could suggest that proteolytic cleavage is a key to the regulation of the adhesive state of S. epidermidis in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550477      PMCID: PMC177689          DOI: 10.1128/jb.178.2.537-541.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene.

Authors:  C P Timmerman; A Fleer; J M Besnier; L De Graaf; F Cremers; J Verhoef
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 2.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Staphylococcus epidermidis infections.

Authors:  F D Lowy; S M Hammer
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

5.  Coagulase-negative staphylococcal septicemia: experience in a newborn intensive care unit.

Authors:  D P Munson; T R Thompson; D E Johnson; F S Rhame; N VanDrunen; P Ferrieri
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

6.  The localisation of phoE and beta-galactosidase antigens in wild type and phoE/1acZ hybrid Escherichia coli.

Authors:  J Leunissen; M van Damme-Jongsten; J Tommassen; B Lugtenberg; A Verkleij
Journal:  Cell Biol Int Rep       Date:  1984-03

7.  Changing blood culture isolates in a referral neonatal intensive care unit.

Authors:  O Battisti; R Mitchison; P A Davies
Journal:  Arch Dis Child       Date:  1981-10       Impact factor: 3.791

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis.

Authors:  G D Christensen; A L Bisno; J T Parisi; B McLaughlin; M G Hester; R W Luther
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

10.  Characterisation and functional aspects of monoclonal antibodies specific for surface proteins of coagulase-negative staphylococci.

Authors:  C P Timmerman; J M Besnier; L De Graaf; R Torensma; A J Verkley; A Fleer; J Verhoef
Journal:  J Med Microbiol       Date:  1991-08       Impact factor: 2.472

View more
  31 in total

Review 1.  Basic aspects of the pathogenesis of staphylococcal polymer-associated infections.

Authors:  C von Eiff; C Heilmann; M Herrmann; G Peters
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress.

Authors:  J K Knobloch; K Bartscht; A Sabottke; H Rohde; H H Feucht; D Mack
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 3.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Bacterial cell attachment, the beginning of a biofilm.

Authors:  Jon Palmer; Steve Flint; John Brooks
Journal:  J Ind Microbiol Biotechnol       Date:  2007-07-06       Impact factor: 3.346

5.  Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein.

Authors:  Miriam A Banner; John G Cunniffe; Robin L Macintosh; Timothy J Foster; Holger Rohde; Dietrich Mack; Emmy Hoyes; Jeremy Derrick; Mathew Upton; Pauline S Handley
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

Review 6.  Staphylococcal biofilms.

Authors:  M Otto
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis.

Authors:  L Pei; M Palma; M Nilsson; B Guss; J I Flock
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 8.  Proteomics dedicated to biofilmology: What have we learned from a decade of research?

Authors:  Arbia Khemiri; Thierry Jouenne; Pascal Cosette
Journal:  Med Microbiol Immunol       Date:  2015-06-12       Impact factor: 3.402

Review 9.  Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms.

Authors:  K Keely Boyle; Stuart Wood; T David Tarity
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

10.  Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation.

Authors:  D Mack; H Rohde; S Dobinsky; J Riedewald; M Nedelmann; J K Knobloch; H A Elsner; H H Feucht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.